share_log

Blonder Tongue Laboratories (NYSE:BDR) Coverage Initiated by Analysts at StockNews.com

Defense World ·  Aug 9, 2022 02:22

Equities research analysts at StockNews.com initiated coverage on shares of Blonder Tongue Laboratories (NYSE:BDR – Get Rating) in a note issued to investors on Tuesday. The firm set a "hold" rating on the stock.

Blonder Tongue Laboratories Trading Up 1.5 %

Shares of BDR opened at $0.31 on Tuesday. The company's 50 day simple moving average is $0.35. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.11 and a quick ratio of 0.38. Blonder Tongue Laboratories has a 12-month low of $0.28 and a 12-month high of $1.91. The company has a market cap of $4.06 million, a P/E ratio of -4.36 and a beta of 0.55.

Get Blonder Tongue Laboratories alerts:

Blonder Tongue Laboratories (NYSE:BDR – Get Rating) last released its quarterly earnings data on Friday, May 6th. The company reported ($0.09) earnings per share (EPS) for the quarter. Blonder Tongue Laboratories had a negative net margin of 4.14% and a negative return on equity of 18.69%. The company had revenue of $3.34 million for the quarter.

Blonder Tongue Laboratories Company Profile

(Get Rating)

Blonder Tongue Laboratories, Inc, a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers encoders/transcoders, such as 4K/ultra-high definition, high definition and standard definition, MPEG-2, MPEG-4/H.264, and HEVC/H.265 capable encoders and transcoders; and QPSK and 8PSK, and QAM transcoders.

Further Reading

  • Get a free copy of the StockNews.com research report on Blonder Tongue Laboratories (BDR)
  • Home Depot, Lowe's On Track To Grow 2022 Earnings
  • Could Smaller be Better for Investors in Norwegian Cruise Lines?
  • Walmart Or Target: Which Is The Stronger Stock?
  • Volume Surges Spark Turnarounds for These 3 Stocks
  • Can Etsy Continue to Thrive After the Pandemic?

Receive News & Ratings for Blonder Tongue Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blonder Tongue Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment